A randomized, open-label, crossover, drug interaction study to evaluate the effects of DVS SR [desvenlafaxine sustained release] and duloxetine on the pharmacokinetics of desipramine in healthy subjects

Trial Profile

A randomized, open-label, crossover, drug interaction study to evaluate the effects of DVS SR [desvenlafaxine sustained release] and duloxetine on the pharmacokinetics of desipramine in healthy subjects

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Dec 2008

At a glance

  • Drugs Desipramine; Desvenlafaxine; Duloxetine
  • Indications Generalised anxiety disorder; Major depressive disorder; Pain; Stress incontinence; Vasomotor symptoms
  • Focus Pharmacokinetics
  • Sponsors Wyeth
  • Most Recent Events

    • 01 Dec 2008 Results were published in Drug Metabolism and Disposition.
    • 05 Dec 2007 Results have been presented at the International Forum on Mood and Anxiety Disorders 2007 (1101137)
    • 25 May 2007 Status changed from planning to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top